Abbott Laboratories (market cap: €142 billion) has been battling Edwards Lifesciences (market cap: €42 billion) in US and UK courts over the Pascal, Edwards' device for fixing leaky heart valves. Now the fight is coming to Ireland.
© 2023 Currency Media Limited
